JAK2 Protein Changes in Male Pattern Baldness With Minoxidil
Treatments studied
Part of Skin clinical trials.
This study examines how a protein called JAK2 changes in the scalp when men with male pattern baldness use minoxidil (Rogaine), a common hair-loss treatment. Understanding this might help explain why minoxidil works and improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 to 50 years old
- You have male pattern baldness (androgenetic alopecia) that is mild to moderate in severity
- You have not used other hair-loss treatments recently, or you are willing to stop them for at least 1 month before starting
- You do not have other types of hair loss, such as scarring alopecia or hair loss from inflammation
- You do not have scalp inflammation conditions like psoriasis or seborrheic dermatitis
- You have not taken JAK inhibitors, immune-suppressing drugs, or systemic steroids in the past 12 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether microneedling (a procedure using tiny needles on the scalp) can safely help regrow hair in men with male pattern baldness. Participants will receive the procedure and be monitored over time with scalp photos.
This study tests an experimental treatment using a substance made from your own hair follicles to see if it can help regrow hair in people with pattern baldness. It involves getting several small injections into your scalp over time.
This study tests an oral pill form of minoxidil, a common hair growth treatment, for men with male pattern baldness. It aims to see if the pill is safe and effective in helping hair regrow.
This trial compares different in-office procedures (like injections, lasers, or platelet-rich plasma) to treat male pattern hair loss. It aims to find which method works best to help hair grow back or stop thinning. Participation could provide access to new treatments that target the root cause of hair loss.
This trial tests a new treatment for male pattern baldness (androgenic alopecia). It is for men with a moderate level of hair loss who have not used any hair loss treatments in the last 90 days.
This Phase 3 study tests whether a specific hair lotion works and is safe for men with male pattern hair loss. It also checks that results are consistent while you keep similar hair care and avoid certain other hair-loss treatments.
Hear when a new Androgenetic Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.